You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

squamous cell carcinoma of the head and neck (SCCHN)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma Trial in Baltimore (Pembrolizumab, IO102-103)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Baltimore, Maryland
    Johns Hopkins University
Aug 2, 2023

Squamous Cell Carcinoma of the Head and Neck (SCCHN), Recurrent Squamous Cell Carcinoma of the Head and Neck, Metastatic Head

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck (SCCHN)
  • +4 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Squamous Cell Carcinoma of Head and Neck, Locally Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • RP3
  • +3 more
  • (no location specified)
Feb 21, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Stanford ([18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.)

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • [18F]F-AraG PET Scan, baseline + post anti-PD-1 therapy.
  • Stanford, California
    Stanford Hospital and Clinics
Dec 1, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Essen (Atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Essen, Germany
    University Hospital Essen
Nov 2, 2022

Squamous Cell Carcinoma of the Head and Neck Trial (Xevinapant, Placebo, cetuximab)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • (no location specified)
Jul 3, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in Shanghai (MRG003, Cetuximab injection, Methotrexate Injection)

Not yet recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Feb 21, 2023

Nivolumab in Squamous Cell Carcinoma of Head & Neck - Patient

Completed
  • Squamous Cell Carcinoma of the Head and Neck
  • Nivolumab
  • Mount Laurel, New Jersey
    Local Institution
May 2, 2022

SCCHN, Squamous Cell Carcinoma Trial in Birmingham (Cisplatin)

Recruiting
  • SCCHN
  • Squamous Cell Carcinoma
  • Birmingham, Alabama
    University of Alabama at Birmingham
Jan 5, 2023

Squamous Cell Carcinoma of the Head and Neck Trial in United States (SNS-301, Pembrolizumab)

Terminated
Has Results
  • Squamous Cell Carcinoma of the Head and Neck
  • San Francisco, California
  • +9 more
Dec 6, 2022

Head Neck Cancer Trial in Baltimore, Chapel Hill, Philadelphia (Pembrolizumab, Intensity Modulated Radiation Therapy)

Active, not recruiting
Has Results
  • Head and Neck Cancer
  • Baltimore, Maryland
  • +2 more
Dec 7, 2022

Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Neck Cancer Metastatic Trial in Baltimore (Nivolumab 480mg and

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • Nivolumab 480mg and surgical resection
  • Baltimore, Maryland
    Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Feb 25, 2022

Colorectal Cancer Metastatic, Squamous Cell Carcinoma of Head and Neck Trial (WU-NK-101 - Dose Escalation, Cetuximab - Dose

Not yet recruiting
  • Colorectal Cancer Metastatic
  • Squamous Cell Carcinoma of Head and Neck
  • WU-NK-101 - Dose Escalation
  • +3 more
  • (no location specified)
Dec 30, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in La Jolla, San Francisco, Torrance (Pembrolizumab)

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • La Jolla, California
  • +2 more
Aug 17, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Italy (Nivolumab 240 MG in 24 ML Injection)

Completed
  • Squamous Cell Carcinoma of Head and Neck
  • Nivolumab 240 MG in 24 ML Injection
  • Bergamo, Italy
  • +22 more
Apr 4, 2023

A Study of Nivolumab in Patients With Head and Neck Cancer.

Active, not recruiting
  • Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck
  • Nivolumab
  • Paris Cedex 5, France
    Local Institution
Mar 23, 2022

Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous

Recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • +5 more
  • Efineptakin alfa
  • San Francisco, California
    University of California San Francisco
Jul 7, 2022

Squamous Cell Carcinoma of the Head and Neck Trial in Pittsburgh (Nivolumab+Relatlimab, Nivolumab+Ipilimumab)

Recruiting
  • Squamous Cell Carcinoma of the Head and Neck
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 13, 2022

Carcinoma, Squamous Cell of Head and Neck Trial in United States (Cetuximab, PD 0332991)

Active, not recruiting
Has Results
  • Carcinoma, Squamous Cell of Head and Neck
  • Cetuximab
  • PD 0332991
  • Atlanta, Georgia
  • +4 more
Nov 1, 2022

First Line Recurrent/Metastatic Squamous Cell Carcinoma of Head

Completed
  • Squamous Cell Carcinoma of the Head and Neck
    • Parsippany, New Jersey
      Medical Data Analytics
    Nov 15, 2021

    Recurrent Head Neck Cancer, Carcinoma, Squamous Cell of Head and Neck Trial in Baltimore, Philadelphia, Pittsburgh

    Recruiting
    • Recurrent Head and Neck Cancer
    • Carcinoma, Squamous Cell of Head and Neck
    • Baltimore, Maryland
    • +3 more
    Mar 25, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in Shanghai (Docetaxel, Nivolumab)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Shanghai, Shanghai, China
      Guo Ye
    Jan 27, 2022

    Carcinoma, Squamous Cell, Head Neck Cancer Trial in Lexington (Cisplatin, XRT)

    Recruiting
    • Carcinoma, Squamous Cell
    • Head and Neck Cancer
    • Lexington, Kentucky
      University of Kentucky
    Nov 17, 2021

    Lung Cancer Non Small Cell, Head and Neck Squamous Cell Carcinoma, Urothelial Carcinoma Bladder Trial in Spain, United Kingdom,

    Recruiting
    • Lung Cancer Non Small Cell
    • +2 more
    • IO102-IO103 in combination with pembrolizumab
    • Duarte, California
    • +18 more
    Dec 15, 2022

    Squamous Cell Carcinoma of Head and Neck Trial in France, Spain, United States (Setanaxib, Pembrolizumab, Placebo)

    Recruiting
    • Squamous Cell Carcinoma of Head and Neck
    • Miami Beach, Florida
    • +28 more
    Jan 19, 2023